We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
276
BridgeBio Pharma
BBIO
$16.5B
$44.5M 0.07%
599,000
+90,866
+18% +$6.59M
CHYM
277
Chime Financial
CHYM
$7.88B
$44.4M 0.07%
2,371,495
+1,502,710
+173% +$34.1M
PEN icon
278
Penumbra
PEN
$12.5B
$44.3M 0.07%
135,000
-15,000
-10% -$5.08M
AME icon
279
Ametek
AME
$55.5B
$44.2M 0.07%
206,241
+23,400
+13% +$5.2M
CRL icon
280
Charles River Laboratories
CRL
$10.9B
$44.2M 0.07%
256,009
-55,648
-18% -$10.3M
PNC icon
281
PNC Financial Services
PNC
$100B
$44.1M 0.07%
211,792
-26,676
-11% -$5.81M
BLD
282
DELISTED
TopBuild
BLD
$43.9M 0.07%
125,000
+79,000
+172% +$35.4M
EYPT icon
283
EyePoint Inc
EYPT
$1.02B
$42.5M 0.07%
3,300,000
-1,400,000
-30% -$20.9M
RELY icon
284
Remitly
RELY
$4.74B
$42.5M 0.07%
2,710,000
+310,000
+13% +$4.59M
DVN icon
285
Devon Energy
DVN
$51.9B
$42.3M 0.07%
841,194
-3,615,098
-81% -$155M
CNR
286
Core Natural Resources Inc
CNR
$4.19B
$41.9M 0.06%
400,000
-575,000
-59% -$54.7M
HESM icon
287
Hess Midstream
HESM
$5.22B
$41.8M 0.06%
1,075,000
-1,600,000
-60% -$59.3M
GM icon
288
General Motors
GM
$74.7B
$41.7M 0.06%
559,786
-282,400
-34% -$22.5M
TER icon
289
Teradyne
TER
$54.8B
$41.6M 0.06%
140,324
-1,100
-0.8% -$307K
AEE icon
290
Ameren
AEE
$31.5B
$41.5M 0.06%
+377,590
New +$40.4M
NXPI icon
291
NXP Semiconductors
NXPI
$68B
$41.4M 0.06%
210,508
+18,300
+10% +$4.05M
APO icon
292
Apollo Global Management
APO
$70.7B
$41.2M 0.06%
370,000
-3,200
-0.9% -$397K
ARES icon
293
Ares Management
ARES
$28.5B
$40.8M 0.06%
373,800
+221,800
+146% +$29.4M
MMM icon
294
3M
MMM
$89B
$40.7M 0.06%
279,969
-66,550
-19% -$10.6M
EW icon
295
Edwards Lifesciences
EW
$47.6B
$40.2M 0.06%
501,866
-1,452,765
-74% -$120M
CTSH icon
296
Cognizant
CTSH
$21.5B
$40.1M 0.06%
653,450
+217,700
+50% +$15.6M
GFS icon
297
GlobalFoundries
GFS
$29.4B
$40M 0.06%
900,000
-50,000
-5% -$2.2M
ADSK icon
298
Autodesk
ADSK
$44.3B
$39.5M 0.06%
164,889
-2,400
-1% -$603K
FIX icon
299
Comfort Systems
FIX
$61B
$39.4M 0.06%
28,584
+3,784
+15% +$4.8M
NVS icon
300
Novartis
NVS
$295B
$39.4M 0.06%
258,000
+157,812
+158% +$24.2M
10 11
12
13 14

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.